Mycronic AB AI Stock Analysis
Want to see SE:MYCR full AI Analyst Report?
Mycronic AB (MYCR) AI Stock Analysis
Mycronic AB
(Nasdaq OMX AB:MYCR)
Mycronic’s strong profitability, high returns, and very low leverage are the primary strengths. These are moderated by weaker free-cash-flow conversion, bearish short-term technical momentum, and a relatively high P/E ratio despite the low dividend yield.
Mycronic AB (MYCR) vs. iShares MSCI Sweden ETF (EWD)
- Market Cap
- SEK 56.79B
- Dividend Yield
- 1.12%
- Average Volume (3M)
- 284.64K
- Price to Earnings (P/E)
- 28.5
- Beta (1Y)
- 0.83
- Revenue Growth
- 16.55%
- EPS Growth
- 14.12%
- Country
- Sweden
- Employees
- 2,875
- Sector
- General
- Sector Strength
- 55
- Industry
- Industrial - Machinery
Mycronic AB Business Overview & Revenue Model
Company Description
Mycronic AB (publ), based in Täby, Sweden, is a global entity dedicated to the creation, production, and sale of advanced manufacturing machinery for the electronics sector. The company operates extensively across Sweden, wider Europe, North and Sout...
How the Company Makes Money
Mycronic makes money primarily by selling high-value capital equipment used in electronics manufacturing and by generating recurring revenue from supporting that installed base. Key revenue streams typically include: (1) System/equipment sales: one-t...
Mycronic AB Financial Statement Overview
Summary
Strong financial profile, supported by improving profitability, a 25.4% return on equity, and exceptionally low debt-to-equity of 4.9%. Cash-flow quality is the main weakness because free cash flow declined to 999 million and conversion from net income weakened.
Income Statement
90Very PositiveBalance Sheet
95Very PositiveCash Flow
78Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.30B | 7.94B | 7.06B | 5.71B | 5.12B | 4.63B |
| Gross Profit | 5.00B | 4.12B | 3.72B | 2.72B | 2.29B | 2.28B |
| EBITDA | 3.06B | 2.30B | 2.37B | 1.51B | 1.16B | 1.26B |
| Net Income | 1.99B | 1.56B | 1.68B | 998.00M | 741.00M | 828.00M |
Balance Sheet | ||||||
| Total Assets | 13.24B | 10.92B | 10.41B | 8.34B | 7.34B | 6.14B |
| Cash, Cash Equivalents and Short-Term Investments | 3.27B | 2.32B | 3.01B | 2.14B | 1.27B | 683.00M |
| Total Debt | 415.00M | 348.00M | 219.00M | 228.00M | 270.00M | 243.00M |
| Total Liabilities | 4.74B | 3.81B | 3.84B | 3.06B | 2.64B | 2.14B |
| Stockholders Equity | 8.50B | 7.11B | 6.53B | 5.25B | 4.66B | 3.96B |
Cash Flow | ||||||
| Free Cash Flow | 999.00M | 1.32B | 1.64B | 1.41B | 712.00M | 908.00M |
| Operating Cash Flow | 2.41B | 1.41B | 1.87B | 1.61B | 853.00M | 998.00M |
| Investing Cash Flow | -462.00M | -1.13B | -500.00M | -195.00M | 67.00M | -1.22B |
| Financing Cash Flow | -818.00M | -862.00M | -552.00M | -447.00M | -382.00M | -437.00M |
Mycronic AB Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:MYCR, the sentiment is Negative. The current price of 290.00 is below the 20-day moving average (MA) of 295.38, below the 50-day MA of 316.30, and above the 200-day MA of 284.84, indicating a neutral trend. The MACD of -7.84 indicates Negative momentum. The RSI at 42.61 is Neutral, neither overbought nor oversold. The STOCH value of 73.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:MYCR.
Mycronic AB Peers Comparison
Overall Rating
SE:MYCR76Outperform
SE:ATCO.B73Outperform
SE:ALFA67Neutral
SE:SAND65Neutral
SE:MTRS60Neutral
SE:NMAN60Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | SEK 56.79B | 28.46 | 25.38% | 1.12% | 16.55% | 14.12% | |
| 73Outperform | SEK 898.02B | 33.91 | 24.21% | 2.98% | 2.72% | 0.11% | |
| 67Neutral | SEK 226.50B | 27.83 | 17.58% | 1.64% | 4.27% | -2.41% | |
| 65Neutral | SEK 454.21B | 23.81 | 18.92% | 1.66% | 14.34% | 29.04% | |
| 60Neutral | SEK 24.99B | 47.07 | 10.12% | 1.17% | -0.19% | 78.46% | |
| 60Neutral | SEK 5.14B | 22.91 | ― | 2.73% | -6.05% | -24.08% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SE:MYCR | Mycronic AB | 290.00 | 85.25 | 41.64% | |
| SE:ALFA | Alfa Laval AB | 548.00 | 108.93 | 24.81% | |
| SE:ATCO.B | Atlas Copco AB (0R82) | 168.00 | 33.69 | 25.09% | |
| SE:SAND | Sandvik AB (UK) | 362.10 | 81.75 | 29.16% | |
| SE:MTRS | Munters Group AB | 136.80 | -25.24 | -15.58% | |
| SE:NMAN | Nederman Holding AB | 146.40 | -6.38 | -4.18% |
Mycronic AB Corporate Events
Mycronic Lifts 2026 Sales Outlook as Global Technologies Drives Earnings Surge
Mycronic AB reported a robust third quarter, with order intake up 10 percent to SEK 2,667 million and net sales jumping 38 percent to SEK 2,356 million, driven mainly by strong performance in Global Technologies across all divisions. EBIT more than d...
Mycronic Names Mikael Wahlsten to Lead Pattern Generators Division
Mycronic AB has appointed longtime executive Mikael Wahlsten as Senior Vice President Pattern Generators and member of the executive management team, effective November 1, 2026, succeeding Charlott Samuelsson, who is retiring after three decades with...
Mycronic Wins SLX Mask Writer Order to Support European Chip Modernization
Mycronic AB has received an order worth between USD 5 million and USD 7 million from an existing customer for its SLX laser mask writer, scheduled for delivery to a European site in the third quarter of 2027. The deal underscores growing demand for m...
Mycronic Wins U.S. Order for Two SLX Semiconductor Mask Writers
Mycronic AB has secured an order from a U.S. customer for two SLX laser mask writers, with a total value estimated between USD 14 million and USD 16 million and delivery scheduled for the first quarter of 2028. The SLX systems, which share technology...
Mycronic sets date for Q3 2026 report and investor webcast
Mycronic has scheduled the release of its third-quarter 2026 report for October 22, 2026, at 8:00 a.m. CEST, followed by a webcast presentation at 10:00 a.m. CEST for analysts, investors and media. The event, led by President and CEO Anders Lindqvist...
Mycronic Appoints Nomination Committee for 2027 AGM
Mycronic AB has appointed the Nomination Committee for its 2027 Annual General Meeting in line with instructions approved at the 2026 AGM. The committee consists of representatives from major shareholders Bure Equity, SEB Funds and the Fourth Swedish...
Mycronic Sets Ambitious Long-Term Growth and Profitability Targets
Mycronic has set new long-term financial targets, aiming to lift net sales to SEK 20 billion in the period 2032–2035 while maintaining an EBIT margin of around 25 percent. The unchanged sustainability goals and requirement that each division deliver...
Mycronic wins USD 21–24 million Prexision 80 Evo order from Asian display customer
Mycronic has received a replacement order from an existing Asian customer for a Prexision 80 Evo mask writer, a high-end system designed to meet the demanding requirements of complex display photomasks. The order, valued between USD 21 million and US...
Mycronic wins new Asian order for SLX semiconductor mask writer
Mycronic’s Pattern Generators division, which supplies mask writers and metrology systems for display and semiconductor manufacturing, has secured a new customer in Asia for its SLX laser mask writer. The order, valued between USD 4 million and 6 mil...
Mycronic wins Asian order for SLX laser mask writer
Mycronic has secured an order valued between USD 5 million and 7 million from an existing customer in Asia for its SLX laser mask writer, with delivery scheduled for the second quarter of 2027. The SLX system, which leverages technology from Mycronic...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 23, 2026
